<?xml version="1.0" encoding="UTF-8"?>
<p>Guan et al
 <xref rid="CIT0018" ref-type="bibr">18</xref> observed that among patients with COVID-19, the circulatory and endocrine co-morbidities were common. Patients with one or more co-morbidities were associated with worse clinical outcomes. Of the 1590 cases, 399 (25.1%) had at least one co-morbidity. The prevalence of specific co-morbidities was; hypertension (269; 16.9%), other cardiovascular diseases (53.7%), diabetes (130; 8.2%), cerebrovascular diseases (30; 1.9%), hepatitis B infections (28; 1.8%), chronic obstructive pulmonary disease (24; 1.5%), chronic kidney diseases (21; 1.3%), malignancy (18; 1.1%) and immunodeficiency (3; 0.2%). At least, single co-morbidity was commonly seen in severe cases than in non-severe cases (32.8% vs 10.3%).
</p>
